DOT 5 Panel Notice

DOT Drug Testing: After January 1, 2018 – Still a 5-Panel

The DOT testing at HHS-certified laboratories is a 5-panel drug test regimen.  As of January 1, 2018, the ‘Opiates’ category was renamed ‘Opioids’:

  • Marijuana (THC)
  • Cocaine
  • Amphetamines
  • Opioids
  • Phencyclidine (PCP)

Under ‘Opioids’, previously ‘Opiates’, DOT testing will continue to include confirmatory testing, when appropriate, for Codeine, Morphine, and 6-AM (heroin).  We added initial and confirmatory testing for the semi-synthetic opioids Hydrocodone, Hydromorphone, Oxycodone, and Oxymorphone to this Opioids group.  Some brand names for the semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®.

Under Amphetamines, DOT testing includes confirmatory testing, when appropriate, for Amphetamine, Methamphetamine, MDMA, and MDA.  To this Amphetamines group, we added initial testing for MDA and removed testing for MDEA.

Since January 1st, we have required confirmation testing for 14 drugs under a 5‑panel test.  Broken out, here is what DOT drug testing looks like:

DOT 5 Panel Profile

Marijuana (THC)
Cocaine
Amphetamines
~Amphetamine
~Methamphetamine
~MDMA
~MDA
Opioids
~Codeine
~Morphine
~6-AM (Heroin)
~Hydrocodone
~Hydromorphone
~Oxycodone
~Oxymorphone
Phencyclidine (PCP)

For DOT testing, what does this mean for collectors, laboratories, MROs, and employers after January 1st ,2018?

  • Collectors will continue to check the 5-panel box in Step 1 of the CCF: That is, the box specified for “THC, COC, PCP, OPI, AMP.”
  • Laboratories will:
  • continue to report to MROs the specific drugs / drug metabolites they confirm as positive, and laboratories will add hydrocodone, hydromorphone, oxycodone, and oxymorphone confirmed positives, as appropriate.
  • on their semi-annual reports to DOT and their semi-annual reports to employers add: hydrocodone; hydromorphone; oxycodone; and oxymorphone confirmed positive totals, as appropriate, under Opioids.
  • MROs will continue to report to employers the specific drugs / drug metabolite they verify as positive; and MROs will add hydrocodone, hydromorphone, oxycodone, and oxymorphone verified positives, as appropriate.
  • Employers will continue to provide – on their annual MIS reports – the number of verified positive drug test results in each testing category (i.e., Marijuana, Cocaine, Amphetamines, Opioids, and PCP).
Updated: Tuesday, March 6, 2018

Aegis Alliance Presenting at LASTO Spring Conference

2018 LASTO Spring Conference – March 7-9

It is with great pleasure that the Managing Member, Christian Brugman, of Aegis Alliance will be presenting at this years Spring Conference to be held at Paragon Casino Resort in Marksville, LA. Mr. Brugman will be conducting a two hour training seminar for DOT Drug & Alcohol Supervisory Training & Certification. The LASTO organization consist of school districts throughout the state of Louisiana.

Mr. Brugman entered the industry in 1993 and since that time has both supported and facilitated numerous operations on five (5) different continents over the past 25 years. With over twenty five years of experience in developing and administering quality substance abuse programs for clients covering a wide range of industries on a national basis of not only implementing drug and alcohol programs but facilitating them as well.

At Aegis Alliance he specializes in the workplace drug and alcohol testing industry with the number one goal of quality service with confidence. This attitude ensures that Aegis Alliance provides the upmost solutions and services to our client base. Aegis Alliance is committed to ‘Total Program Management’ implementing drug and alcohol programs from their very birth to also supporting existing established programs.

The use of Aegis Alliance’s “Total Program Management” solution provides distinct benefits to every Client allied with Aegis Alliance. We will earn your trust and confidence, not only from the TPM implementation, but throughout the entire Alliance process.  Our mission statement sums it up best:

  “Aegis Alliance Seeks to Create, Promote, And Ensure a Drug-Free Workplace Specific to Every Client’s Needs.  We Strive to Grow Our Business Based on Honesty and Integrity with Customer Service as Priority.”

FAA, PMHSA, FRA & Coast Guard Announce 2018 Random Testing Rates

In December 2017, the Federal Railroad Administration (FRA), Federal Aviation Administration (FAA), and the Pipeline and Hazardous Materials Safety Administration (PMHSA) all announced their random testing rates for 2018. The U.S. Coast Guard (CG) announced its rates in January 2018. No announcements have been made regarding random testing rates by the Federal Motor Carriers Safety Administration (FMCSA) or the Federal Transit Administration (FTA). DATIA will notify members when those rates are announced.

Summary:

– FRA 25% Drug, 10% Alcohol – ** (MOW) Rates – 50% Drug, 25% Alcohol

– PMHSA 50% Drug, N/A Alcohol

– FAA 25% Drug, 10% Alcohol

– USCG 25% Drug, N/A Alcohol

– FMCSA – Not Yet Announced

– FTA – Not Yet Announced